| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Michael J Grace | |
| Diana L Brassard | |||
| Ronald W Bordens | |||
| P433 | issue | 4 | |
| P921 | main subject | immunotherapy | Q1427096 |
| P304 | page(s) | 565-581 | |
| P577 | publication date | 2002-04-01 | |
| P1433 | published in | Journal of Leukocyte Biology | Q1524048 |
| P1476 | title | Interferon-alpha as an immunotherapeutic protein | |
| P478 | volume | 71 |
| Q61810307 | A Glycoengineered Interferon-β Mutein (R27T) Generates Prolonged Signaling by an Altered Receptor-Binding Kinetics |
| Q39063204 | A Recombinant Adenovirus Expressing Ovine Interferon Tau Prevents Influenza Virus-Induced Lethality in Mice |
| Q37708659 | A review of the epidemiological and clinical aspects of West Nile virus |
| Q36862918 | A simple engineered platform reveals different modes of tumor-microenvironmental cell interaction |
| Q27473105 | Activation of anti-hepatitis C virus responses via Toll-like receptor 7. |
| Q37088489 | Anti-CD20-interferon-β fusion protein therapy of murine B-cell lymphomas |
| Q39264002 | Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses |
| Q41005491 | Antiviral treatment with alpha interferon up-regulates CD14 on liver macrophages and its soluble form in patients with chronic hepatitis B. |
| Q27318249 | Association of TLR7 variants with AIDS-like disease and AIDS vaccine efficacy in rhesus macaques |
| Q34120302 | Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells |
| Q38402634 | Converting Lymphoma Cells into Potent Antigen-Presenting Cells for Interferon-Induced Tumor Regression. |
| Q24814274 | Delayed polarization of mononuclear phagocyte transcriptional program by type I interferon isoforms |
| Q33725882 | Dendritic cells from HIV-1 infected individuals are less responsive to toll-like receptor (TLR) ligands. |
| Q42857638 | Different physiology of interferon-α/-γ in models of liver regeneration in the rat. |
| Q36464593 | Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4⁺ T cells from patients with GI malignancy |
| Q37481254 | Elimination of N-glycosylation by site mutation further prolongs the half-life of IFN-α/Fc fusion proteins expressed in Pichia pastoris |
| Q39807024 | Enhancement of reporter gene detection sensitivity by insertion of specific mini-peptide-coding sequences |
| Q36433538 | Evaluation of Different Strategies for Post-Exposure Treatment of Ebola Virus Infection in Rodents. |
| Q37000665 | Field production and functional evaluation of chloroplast-derived interferon-alpha2b |
| Q34009002 | Hepatitis C virus infection suppresses the interferon response in the liver of the human hepatocyte chimeric mouse |
| Q37070203 | Immunomodulatory cytokines as therapeutic agents for melanoma |
| Q58585560 | Immunotherapy Through the Years |
| Q35560718 | Impaired NK Cell Responses to Pertussis and H1N1 Influenza Vaccine Antigens in Human Cytomegalovirus-Infected Individuals |
| Q41684504 | In-vitro antiviral efficacy of ribavirin and interferon-alpha against canine distemper virus. |
| Q39948674 | Ingested Type I Interferon-State of the Art as Treatment for Autoimmunity Part 2 |
| Q37687020 | Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer. |
| Q37594928 | Interferon-Alpha Promotes Th1 Response and Epithelial Apoptosis via Inflammasome Activation in Human Intestinal Mucosa |
| Q34242165 | Interferon-alpha produces significant decreases in HIV load |
| Q37406596 | Interferons and their potential in the treatment of ocular inflammation |
| Q34242185 | Interleukin-27, an anti-HIV-1 cytokine, inhibits replication of hepatitis C virus |
| Q24797820 | Interpreting interest in interferon-alpha |
| Q28550109 | Intrapericardial Delivery of Cardiosphere-Derived Cells: An Immunological Study in a Clinically Relevant Large Animal Model |
| Q28070375 | Is Optimal Management of Recurrent Aphthous Stomatitis Possible? A Reality Check |
| Q27339244 | Loss of Ifnar1 in Pancreatic Acinar Cells Ameliorates the Disease Course of Acute Pancreatitis |
| Q38036202 | NK cells: key to success of DC-based cancer vaccines? |
| Q24612339 | Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model |
| Q24815995 | Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication |
| Q21195364 | Overview of the biology of type I interferons |
| Q35185439 | Paramyxovirus infection regulates T cell responses by BDCA-1+ and BDCA-3+ myeloid dendritic cells |
| Q57159202 | Perspectives on interferon-alpha in the treatment of Polycythemia vera and related Myeloproliferative neoplasms: minimal residual disease and cure? |
| Q36305520 | Potent antitumor effects of combination therapy with IFNs and monocytes in mouse models of established human ovarian and melanoma tumors |
| Q37551110 | Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers |
| Q36437015 | Protein tyrosine phosphatase 1B is a key regulator of IFNAR1 endocytosis and a target for antiviral therapies |
| Q35784113 | Re-evaluation of antitumor effects of combination chemotherapy with interferon-alpha and 5-fluorouracil for advanced hepatocellular carcinoma |
| Q36574519 | Reovirus-mediated cytotoxicity and enhancement of innate immune responses against acute myeloid leukemia |
| Q42945461 | Respiratory syncytial virus infection in Fischer 344 rats is attenuated by short interfering RNA against the RSV-NS1 gene |
| Q26777659 | Ribavirin contributes to eradicate hepatitis C virus through polarization of T helper 1/2 cell balance into T helper 1 dominance |
| Q27473359 | Ribavirin in cancer immunotherapies: controlling nitric oxide augments cytotoxic lymphocyte function |
| Q41332123 | Role of dendritic cells in cardiovascular diseases |
| Q34702799 | Screening and identification of genetic loci involved in producing more/denser inclusion bodies in Escherichia coli |
| Q24545838 | Sendai virus infection induces efficient adaptive immunity independently of type I interferons |
| Q34478750 | Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse model |
| Q35848849 | Stimulated plasmacytoid dendritic cells impair human T-cell development |
| Q54347558 | Synthesis and expression of recombinant interferon alpha-5 gene in tobacco chloroplasts, a non-edible plant. |
| Q33788697 | Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma |
| Q39045958 | The role of the immune system in neurofibromatosis type 1-associated nervous system tumors |
| Q34545693 | Toll-like receptor-independent triggering of dendritic cell maturation by viruses. |
| Q35311846 | Trained immunity in newborn infants of HBV-infected mothers |
| Q28509359 | Twist mediates suppression of inflammation by type I IFNs and Axl |
| Q37620420 | Type I interferons induced by radiation therapy mediate recruitment and effector function of CD8(+) T cells |
| Q28743512 | Use of recombinant adenovirus vectored consensus IFN-α to avert severe arenavirus infection |
| Q42551996 | Virus-induced unfolded protein response attenuates antiviral defenses via phosphorylation-dependent degradation of the type I interferon receptor |
| Q35833086 | Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C. |
| Q40228190 | West Nile Virus Infection in the Immunocompromised Patient |
Search more.